Quarterly report pursuant to Section 13 or 15(d)

Concentrations

v3.24.1.1.u2
Concentrations
3 Months Ended
Mar. 31, 2024
Risks and Uncertainties [Abstract]  
Concentrations

NOTE 12—CONCENTRATIONS

Revenue from the Company’s products are as follows (dollars in thousands):

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2024

 

 

2023

 

Laser systems

 

$

5,175

 

 

 

51.1

%

 

$

6,265

 

 

 

59.8

%

Consumables and other

 

 

3,469

 

 

 

34.2

%

 

 

3,033

 

 

 

29.0

%

Services

 

 

1,487

 

 

 

14.7

%

 

 

1,169

 

 

 

11.2

%

Net revenue

 

$

10,131

 

 

 

100.0

%

 

$

10,467

 

 

 

100.0

%

 

No individual customer represented more than 10% of the Company’s revenue for the three months ended March 31, 2024 or 2023.

The Company maintains its cash and cash equivalents in money market investment accounts with established commercial banks. Such cash deposits periodically exceed the Federal Deposit Insurance Corporation insured limit.

No individual customer represented more than 10% of the Company’s accounts receivable as of March 31, 2024. As of December 31, 2023 accounts receivable from one customer totaled approximately 11% of total gross accounts receivable which has been partially received on in 2024.

The Company currently purchases certain key components of its products from single suppliers. Although there are a limited number of manufacturers of these key components, management believes that other suppliers could provide similar key components on comparable terms. A change in suppliers, however, could cause delays in manufacturing and a possible loss of sales, which could adversely affect the Company’s business, results of operations and financial condition.